SEC Form 4 · accession 0001193125-26-290902
Disc Medicine, Inc. · IRON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rahul Khara
Officer — Chief Legal Officer
Period of report
Jun 26, 2026
Accepted (ET)
Jun 30, 2026 · 5:49 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001816736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 26, 2026 | M | 851 | $14.69 | A | 53,024 | D | |
| Common Stock | Jun 26, 2026 | S | 851 | $75.00 | D | 52,173 | D | |
| Common Stock | Jun 29, 2026 | M | 1,649 | $14.69 | A | 53,822 | D | |
| Common Stock | Jun 29, 2026 | S | 1,649 | $75.00 | D | 52,173 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $14.69 | Jun 26, 2026 | M | 851 | D | — | Feb 7, 2032 | Common Stock | 851 | 56,453 | D |
| Stock Option (Right to Buy)F2 | $14.69 | Jun 29, 2026 | M | 1,649 | D | — | Feb 7, 2032 | Common Stock | 1,649 | 54,804 | D |
Explanation of responses
- F1The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.
- F2The shares underlying this option are fully vested and exercisable as of the date hereof.